PMID- 11606073 OWN - NLM STAT- MEDLINE DCOM- 20011205 LR - 20051117 IS - 0090-8258 (Print) IS - 0090-8258 (Linking) VI - 83 IP - 2 DP - 2001 Nov TI - Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer. PG - 205-15 AB - OBJECTIVE: The purpose of this study was to examine the relationship of hepatocyte growth factor/scatter factor (HGF/SF) to cell motility and invasion in uterine cervical cancer. METHODS: We examined the expression of HGF/SF and its receptor, c-met, in cervical cancer cell lines SKG-IIIa (squamous cell carcinoma) and Hela-S3 (adenocarcinoma) and in stromal cells of the cervical cancer tissue by reverse transcription-polymerase chain reaction. We studied the effect of HGF/SF on invasiveness of SKG-IIIa and Hela-S3 in an invasion model of the modified Boyden chamber method and by electron microscopy. SKG-IIIa cells were also seeded on the thick Matrigel-coated layer to evaluate the invasion patterns in three-dimensional directions. To investigate the mechanism of an inductive effect of HGF/SF on the invasiveness of SKG-IIIa, we examined the effect of HGF/SF on the expression of intercellular adhesion molecule E-cadherin, cell-substrate adhesion molecules CD44, alpha2beta1, and alpha6beta1, and intracellular skeleton fiber actin in SKG-IIIa in cell enzyme-linked immunosorbent assay (ELISA) and immunofluorescence staining. RESULTS: HGF/SF messenger RNA (mRNA) was detected in stromal cells, and c-met mRNA was detected in SKG-IIIa and Hela-S3. Hela-S3 that initially showed weak intercellular contact freely invaded the Matrigel-coated multiporous membrane without the addition of HGF/SF. In contrast, SKG-IIIa that initially showed strong intercellular adhesion could invade the membrane after the addition of HGF/SF. The same results were represented by an addition of HECD-1, an anti-human E-cadherin antibody. In an experiment with cell culture in a thick Matrigel layer, control SKG-IIIa showed a mirror-ball-like invasion pattern, whereas HGF/SF-stimulated SKG-IIIa spread horizontally over the membrane and migrated through the membrane holes, presenting a tentacular invasion pattern. Migration of SKG-IIIa under the membrane was confirmed by scanning and transmission electron microscopy. The addition of HGF/SF in cell ELISA assay decreased the expression of E-cadherin and actin in SKG-IIIa, but it did not change the expression of CD44, alpha2beta1, and alpha6beta1. Immunofluorescence staining revealed that the expression of E-cadherin in cell membrane was disturbed by HGF/SF. CONCLUSIONS: Our data indicate that HGF/SF produced by stromal cells influences the mode of stromal invasion of squamous cervical cancer by selectively decreasing the expression of both E-cadherin and actin. CI - Copyright 2001 Academic Press. FAU - Shimabukuro, K AU - Shimabukuro K AD - Comprehensive Reproductive Medicine, Graduate School, Tokyo, Japan. shima-hs@d9.dion.ne.jp FAU - Ichinose, S AU - Ichinose S FAU - Koike, R AU - Koike R FAU - Kubota, T AU - Kubota T FAU - Yamaguchi, M AU - Yamaguchi M FAU - Miyasaka, M AU - Miyasaka M FAU - Aso, T AU - Aso T LA - eng PT - Journal Article PL - United States TA - Gynecol Oncol JT - Gynecologic oncology JID - 0365304 RN - 0 (Actins) RN - 0 (Cadherins) RN - 0 (Cell Adhesion Molecules) RN - 0 (RNA, Messenger) RN - 67256-21-7 (Hepatocyte Growth Factor) SB - IM MH - Actins/biosynthesis MH - Adenocarcinoma/metabolism/pathology MH - Cadherins/biosynthesis MH - Carcinoma, Squamous Cell/metabolism/*pathology MH - Cell Adhesion Molecules/biosynthesis MH - Cell Movement/physiology MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Fluorescent Antibody Technique MH - HeLa Cells MH - Hepatocyte Growth Factor/biosynthesis/genetics/*physiology MH - Humans MH - Neoplasm Invasiveness MH - RNA, Messenger/biosynthesis/genetics MH - Reverse Transcriptase Polymerase Chain Reaction MH - Stromal Cells/metabolism/pathology MH - Tumor Cells, Cultured MH - Uterine Cervical Neoplasms/metabolism/*pathology EDAT- 2001/10/19 10:00 MHDA- 2002/01/05 10:01 CRDT- 2001/10/19 10:00 PHST- 2001/10/19 10:00 [pubmed] PHST- 2002/01/05 10:01 [medline] PHST- 2001/10/19 10:00 [entrez] AID - S0090-8258(01)96347-4 [pii] AID - 10.1006/gyno.2001.6347 [doi] PST - ppublish SO - Gynecol Oncol. 2001 Nov;83(2):205-15. doi: 10.1006/gyno.2001.6347.